{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:50:24Z","timestamp":1767772224241,"version":"3.37.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,10,29]],"date-time":"2015-10-29T00:00:00Z","timestamp":1446076800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,10,29]],"date-time":"2015-10-29T00:00:00Z","timestamp":1446076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA123451"],"award-info":[{"award-number":["CA123451"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s11060-015-1970-3","type":"journal-article","created":{"date-parts":[[2015,10,29]],"date-time":"2015-10-29T10:59:20Z","timestamp":1446116360000},"page":"317-325","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Tryptophan PET predicts spatial and temporal patterns of post-treatment glioblastoma progression detected by contrast-enhanced MRI"],"prefix":"10.1007","volume":"126","author":[{"given":"Edit","family":"Bosny\u00e1k","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David O.","family":"Kamson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha L.","family":"Robinette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey R.","family":"Barger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Csaba","family":"Juh\u00e1sz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,29]]},"reference":[{"key":"1970_CR1","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1001\/jama.2013.280319","volume":"310","author":"A Omuro","year":"2013","unstructured":"Omuro A, DeAngelis LM (2013) Glioblastoma and other malignant gliomas: a clinical review. JAMA 310:1842\u20131850","journal-title":"JAMA"},{"key":"1970_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO, European Organisation for R, Treatment of Cancer Brain T, Radiation Oncology G, National Cancer Institute of Canada Clinical Trials G (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459\u2013466","journal-title":"Lancet Oncol"},{"key":"1970_CR3","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1093\/neuonc\/nou147","volume":"16","author":"Q Xie","year":"2014","unstructured":"Xie Q, Mittal S, Berens ME (2014) Targeting adaptive glioblastoma: an overview of proliferation and invasion. Neuro Oncol 16:1575\u20131584","journal-title":"Neuro Oncol"},{"key":"1970_CR4","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S1474-4422(10)70181-2","volume":"9","author":"FG Dhermain","year":"2010","unstructured":"Dhermain FG, Hau P, Lanfermann H, Jacobs AH, van den Bent MJ (2010) Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas. Lancet Neurol 9:906\u2013920","journal-title":"Lancet Neurol"},{"key":"1970_CR5","doi-asserted-by":"publisher","first-page":"W654","DOI":"10.2214\/AJR.12.9168","volume":"200","author":"T Nihashi","year":"2013","unstructured":"Nihashi T, Dahabreh IJ, Terasawa T (2013) PET in the clinical management of glioma: evidence map. AJR Am J Roentgenol 200:W654\u2013W660","journal-title":"AJR Am J Roentgenol"},{"key":"1970_CR6","first-page":"173","volume":"56","author":"B Gulyas","year":"2012","unstructured":"Gulyas B, Halldin C (2012) New PET radiopharmaceuticals beyond FDG for brain tumor imaging. Q J Nucl Med Mol Imaging 56:173\u2013190","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"1970_CR7","doi-asserted-by":"publisher","DOI":"10.2310\/7290.2014.00015","author":"C Juhasz","year":"2014","unstructured":"Juhasz C, Dwivedi S, Kamson DO, Michelhaugh SK, Mittal S (2014) Comparison of amino acid positron emission tomographic radiotracers for molecular imaging of primary and metastatic brain tumors. Mol Imaging. doi:\n                    10.2310\/7290.2014.00015","journal-title":"Mol Imaging"},{"key":"1970_CR8","doi-asserted-by":"publisher","first-page":"694","DOI":"10.2967\/jnumed.107.048082","volume":"49","author":"Y Terakawa","year":"2008","unstructured":"Terakawa Y, Tsuyuguchi N, Iwai Y, Yamanaka K, Higashiyama S, Takami T, Ohata K (2008) Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. J Nucl Med 49:694\u2013699","journal-title":"J Nucl Med"},{"key":"1970_CR9","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3171\/jns.2005.103.3.0498","volume":"103","author":"T Nariai","year":"2005","unstructured":"Nariai T, Tanaka Y, Wakimoto H, Aoyagi M, Tamaki M, Ishiwata K, Senda M, Ishii K, Hirakawa K, Ohno K (2005) Usefulness of L-[methyl-11C] methionine-positron emission tomography as a biological monitoring tool in the treatment of glioma. J Neurosurg 103:498\u2013507","journal-title":"J Neurosurg"},{"key":"1970_CR10","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1227\/01.NEU.0000171642.49553.B0","volume":"57","author":"W Rachinger","year":"2005","unstructured":"Rachinger W, Goetz C, Popperl G, Gildehaus FJ, Kreth FW, Holtmannspotter M, Herms J, Koch W, Tatsch K, Tonn JC (2005) Positron emission tomography with O-(2-[18F]fluoroethyl)-l-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas. Neurosurgery 57:505\u2013511","journal-title":"Neurosurgery"},{"key":"1970_CR11","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s002590050541","volume":"27","author":"WA Weber","year":"2000","unstructured":"Weber WA, Wester HJ, Grosu AL, Herz M, Dzewas B, Feldmann HJ, Molls M, Stocklin G, Schwaiger M (2000) O-(2-[18F]fluoroethyl)-l-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study. Eur J Nucl Med 27:542\u2013549","journal-title":"Eur J Nucl Med"},{"key":"1970_CR12","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.ijrobp.2010.07.002","volume":"81","author":"AL Grosu","year":"2011","unstructured":"Grosu AL, Astner ST, Riedel E, Nieder C, Wiedenmann N, Heinemann F, Schwaiger M, Molls M, Wester HJ, Weber WA (2011) An interindividual comparison of O-(2-[18F]fluoroethyl)-l-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases. Int J Radiat Oncol Biol Phys 81:1049\u20131058","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1970_CR13","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s00259-001-0690-4","volume":"29","author":"JK Chung","year":"2002","unstructured":"Chung JK, Kim YK, Kim SK, Lee YJ, Paek S, Yeo JS, Jeong JM, Lee DS, Jung HW, Lee MC (2002) Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET. Eur J Nucl Med Mol Imaging 29:176\u2013182","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1970_CR14","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00259-004-1598-6","volume":"32","author":"S Kim","year":"2005","unstructured":"Kim S, Chung JK, Im SH, Jeong JM, Lee DS, Kim DG, Jung HW, Lee MC (2005) 11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET. Eur J Nucl Med Mol Imaging 32:52\u201359","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1970_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jocn.2009.05.009","volume":"17","author":"EW Lau","year":"2010","unstructured":"Lau EW, Drummond KJ, Ware RE, Drummond E, Hogg A, Ryan G, Grigg A, Callahan J, Hicks RJ (2010) Comparative PET study using F-18 FET and F-18 FDG for the evaluation of patients with suspected brain tumour. J Clin Neurosci 17:43\u201349","journal-title":"J Clin Neurosci"},{"key":"1970_CR16","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1007\/s00330-010-1819-2","volume":"20","author":"M Plotkin","year":"2010","unstructured":"Plotkin M, Blechschmidt C, Auf G, Nyuyki F, Geworski L, Denecke T, Brenner W, Stockhammer F (2010) Comparison of F-18 FET-PET with F-18 FDG-PET for biopsy planning of non-contrast-enhancing gliomas. Eur Radiol 20:2496\u20132502","journal-title":"Eur Radiol"},{"key":"1970_CR17","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.2967\/jnumed.111.097881","volume":"53","author":"B Alkonyi","year":"2012","unstructured":"Alkonyi B, Barger GR, Mittal S, Muzik O, Chugani DC, Bahl G, Robinette NL, Kupsky WJ, Chakraborty PK, Juhasz C (2012) Accurate differentiation of recurrent gliomas from radiation injury by kinetic analysis of alpha-11C-methyl-l-tryptophan PET. J Nucl Med 53:1058\u20131064","journal-title":"J Nucl Med"},{"key":"1970_CR18","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1093\/neuonc\/nou042","volume":"16","author":"DO Kamson","year":"2014","unstructured":"Kamson DO, Mittal S, Robinette NL, Muzik O, Kupsky WJ, Barger GR, Juhasz C (2014) Increased tryptophan uptake on PET has strong independent prognostic value in patients with a previously treated high-grade glioma. Neuro Oncol 16:1373\u20131383","journal-title":"Neuro Oncol"},{"key":"1970_CR19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/00004647-200001000-00002","volume":"20","author":"DC Chugani","year":"2000","unstructured":"Chugani DC, Muzik O (2000) Alpha[C-11]methyl-l-tryptophan PET maps brain serotonin synthesis and kynurenine pathway metabolism. J Cereb Blood Flow Metab 20:2\u20139","journal-title":"J Cereb Blood Flow Metab"},{"key":"1970_CR20","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/s11307-009-0225-0","volume":"11","author":"CE Batista","year":"2009","unstructured":"Batista CE, Juhasz C, Muzik O, Kupsky WJ, Barger G, Chugani HT, Mittal S, Sood S, Chakraborty PK, Chugani DC (2009) Imaging correlates of differential expression of indoleamine 2,3-dioxygenase in human brain tumors. Mol Imaging Biol 11:460\u2013466","journal-title":"Mol Imaging Biol"},{"key":"1970_CR21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11060-013-1043-4","volume":"112","author":"DO Kamson","year":"2013","unstructured":"Kamson DO, Juhasz C, Buth A, Kupsky WJ, Barger GR, Chakraborty PK, Muzik O, Mittal S (2013) Tryptophan PET in pretreatment delineation of newly-diagnosed gliomas: MRI and histopathologic correlates. J Neurooncol 112:121\u2013132","journal-title":"J Neurooncol"},{"key":"1970_CR22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40644-015-0045-1","volume":"15","author":"JW Jeong","year":"2015","unstructured":"Jeong JW, Juhasz C, Mittal S, Bosnyak E, Kamson DO, Barger GR, Robinette NL, Kupsky WJ, Chugani DC (2015) Multi-modal imaging of tumor cellularity and tryptophan metabolism in human gliomas. Cancer Imaging 15:10. doi:\n                    10.1186\/s40644-015-0045-1","journal-title":"Cancer Imaging"},{"key":"1970_CR23","doi-asserted-by":"publisher","first-page":"10152","DOI":"10.1073\/pnas.0702916104","volume":"104","author":"ED Kirson","year":"2007","unstructured":"Kirson ED, Dbaly V, Tovarys F, Vymazal J, Soustiel JF, Itzhaki A, Mordechovich D, Steinberg-Shapira S, Gurvich Z, Schneiderman R, Wasserman Y, Salzberg M, Ryffel B, Goldsher D, Dekel E, Palti Y (2007) Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors. Proc Natl Acad Sci USA 104:10152\u201310157","journal-title":"Proc Natl Acad Sci USA"},{"key":"1970_CR24","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1016\/j.ejca.2012.04.011","volume":"48","author":"R Stupp","year":"2012","unstructured":"Stupp R, Wong ET, Kanner AA, Steinberg D, Engelhard H, Heidecke V, Kirson ED, Taillibert S, Liebermann F, Dbaly V, Ram Z, Villano JL, Rainov N, Weinberg U, Schiff D, Kunschner L, Raizer J, Honnorat J, Sloan A, Malkin M, Landolfi JC, Payer F, Mehdorn M, Weil RJ, Pannullo SC, Westphal M, Smrcka M, Chin L, Kostron H, Hofer S, Bruce J, Cosgrove R, Paleologous N, Palti Y, Gutin PH (2012) NovoTTF-100A versus physician\u2019s choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality. Eur J Cancer 48:2192\u20132202","journal-title":"Eur J Cancer"},{"key":"1970_CR25","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jocn.2014.09.018","volume":"22","author":"HR Kim","year":"2015","unstructured":"Kim HR, Kim KH, Kong DS, Seol HJ, Nam DH, Lim do H, Lee JI (2015) Outcome of salvage treatment for recurrent glioblastoma. J Clin Neurosci 22:468\u2013473","journal-title":"J Clin Neurosci"},{"key":"1970_CR26","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, European Organisation for R, Treatment of Cancer Brain T, Radiotherapy G, National Cancer Institute of Canada Clinical Trials G (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996","journal-title":"N Engl J Med"},{"key":"1970_CR27","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S0969-8051(96)00127-8","volume":"23","author":"PK Chakraborty","year":"1996","unstructured":"Chakraborty PK, Mangner TJ, Chugani DC, Muzik O, Chugani HT (1996) A high-yield and simplified procedure for the synthesis of alpha-[11C]methyl-l-tryptophan. Nucl Med Biol 23:1005\u20131008","journal-title":"Nucl Med Biol"},{"key":"1970_CR28","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/sj.jcbfm.9600199","volume":"26","author":"C Juhasz","year":"2006","unstructured":"Juhasz C, Chugani DC, Muzik O, Wu D, Sloan AE, Barger G, Watson C, Shah AK, Sood S, Ergun EL, Mangner TJ, Chakraborty PK, Kupsky WJ, Chugani HT (2006) In vivo uptake and metabolism of alpha-[11C]methyl-L-tryptophan in human brain tumors. J Cereb Blood Flow Metab 26:345\u2013357","journal-title":"J Cereb Blood Flow Metab"},{"key":"1970_CR29","first-page":"6982","volume":"2011","author":"R Kikinis","year":"2011","unstructured":"Kikinis R, Pieper S (2011) 3D Slicer as a tool for interactive brain tumor segmentation. Conf Proc IEEE Eng Med Biol Soc 2011:6982\u20136984","journal-title":"Conf Proc IEEE Eng Med Biol Soc"},{"key":"1970_CR30","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1109\/TMI.2003.809072","volume":"22","author":"D Mattes","year":"2003","unstructured":"Mattes D, Haynor DR, Vesselle H, Lewellen TK, Eubank W (2003) PET-CT image registration in the chest using free-form deformations. IEEE Trans Med Imaging 22:120\u2013128","journal-title":"IEEE Trans Med Imaging"},{"key":"1970_CR31","doi-asserted-by":"publisher","first-page":"7163","DOI":"10.1158\/1078-0432.CCR-04-0262","volume":"10","author":"LW Kracht","year":"2004","unstructured":"Kracht LW, Miletic H, Busch S, Jacobs AH, Voges J, Hoevels M, Klein JC, Herholz K, Heiss WD (2004) Delineation of brain tumor extent with [11C]l-methionine positron emission tomography: local comparison with stereotactic histopathology. Clin Cancer Res 10:7163\u20137170","journal-title":"Clin Cancer Res"},{"key":"1970_CR32","first-page":"411","volume":"46","author":"D Pauleit","year":"2005","unstructured":"Pauleit D, Stoffels G, Schaden W, Hamacher K, Bauer D, Tellmann L, Herzog H, Broer S, Coenen HH, Langen KJ (2005) PET with O-(2-18F-Fluoroethyl)-l-Tyrosine in peripheral tumors: first clinical results. J Nucl Med 46:411\u2013416","journal-title":"J Nucl Med"},{"key":"1970_CR33","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/0360-3016(89)90941-3","volume":"16","author":"KE Wallner","year":"1989","unstructured":"Wallner KE, Galicich JH, Krol G, Arbit E, Malkin MG (1989) Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 16:1405\u20131409","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1970_CR34","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0167-8140(99)00117-6","volume":"53","author":"U Oppitz","year":"1999","unstructured":"Oppitz U, Maessen D, Zunterer H, Richter S, Flentje M (1999) 3D-recurrence-patterns of glioblastomas after CT-planned postoperative irradiation. Radiother Oncol 53:53\u201357","journal-title":"Radiother Oncol"},{"key":"1970_CR35","doi-asserted-by":"publisher","first-page":"698","DOI":"10.3171\/jns.1988.68.5.0698","volume":"68","author":"PC Burger","year":"1988","unstructured":"Burger PC, Heinz ER, Shibata T, Kleihues P (1988) Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg 68:698\u2013704","journal-title":"J Neurosurg"},{"key":"1970_CR36","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","volume":"28","author":"PY Wen","year":"2010","unstructured":"Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, Degroot J, Wick W, Gilbert MR, Lassman AB, Tsien C, Mikkelsen T, Wong ET, Chamberlain MC, Stupp R, Lamborn KR, Vogelbaum MA, van den Bent MJ, Chang SM (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 28:1963\u20131972","journal-title":"J Clin Oncol"},{"key":"1970_CR37","doi-asserted-by":"publisher","first-page":"540","DOI":"10.2967\/jnumed.113.129007","volume":"55","author":"CP Filss","year":"2014","unstructured":"Filss CP, Galldiks N, Stoffels G, Sabel M, Wittsack HJ, Turowski B, Antoch G, Zhang K, Fink GR, Coenen HH, Shah NJ, Herzog H, Langen KJ (2014) Comparison of 18F-FET PET and perfusion-weighted MR imaging: a PET\/MR imaging hybrid study in patients with brain tumors. J Nucl Med 55:540\u2013545","journal-title":"J Nucl Med"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-015-1970-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-015-1970-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-015-1970-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-015-1970-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T07:19:04Z","timestamp":1589699944000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-015-1970-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,29]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["1970"],"URL":"https:\/\/doi.org\/10.1007\/s11060-015-1970-3","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"type":"print","value":"0167-594X"},{"type":"electronic","value":"1573-7373"}],"subject":[],"published":{"date-parts":[[2015,10,29]]},"assertion":[{"value":"14 April 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None of the authors report any conflict of interest or disclosure.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}